1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.006 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlersMcVernon, J.; Nolan, T.; Richmond, P.; Reynolds, G.; Nissen, M.; Lambert, S.; Marshall, H.; Papa, T.; Rehm, C.
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2007A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infantsNolan, T.; Lambert, S.; Roberton, D.; Marshall, H.; Richmond, P.; Streeton, C.; Poolman, J.; Boutriau, D.
2011Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of ageBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2006A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 yearsMarshall, H.; Nolan, T.; Roberton, D.; Richmond, P.; Lambert, S.; Jacquet, J.; Schuerman, L.
2006Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A reviewJacquet, J.; Begue, P.; Grimprel, E.; Reinert, P.; Sandbu, S.; Silfverdal, S.; Faldella, G.; Nolan, T.; Lambert, S.; Richmond, P.; Marshall, H.; Roberton, D.; Schuerman, L.
2007DTPa-HBV-IPV vaccine for primary vaccination of infantsNolan, T.; Lambert, S.; Roberton, D.; Marshall, H.; Richmond, P.; Streeton, C.
2012Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsBryant, K.; McVernon, J.; Marchant, C.; Nolan, T.; Marshall, G.; Richmond, P.; Marshall, H.; Nissen, M.; Lambert, S.; Aris, E.; Mesaros, N.; Miller, J.

Discover